These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19177434)

  • 1. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients.
    Cabrera R; Ararat M; Soldevila-Pico C; Dixon L; Pan JJ; Firpi R; Machicao V; Levy C; Nelson D; Morelli G
    Liver Transpl; 2009 Feb; 15(2):216-22. PubMed ID: 19177434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K; Miller C; Hirose K; Diago T; Aucejo F; Quintini C; Eghtesad B; Corey R; Yerian L; Lopez R; Zein N; Fung J
    Clin Transplant; 2010; 24(5):701-8. PubMed ID: 20047619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an immune functional assay to differentiate recurrent hepatitis C from acute cellular rejection in liver transplant patients.
    Rubinas T; Dellon E; Henel G
    Liver Transpl; 2009 Sep; 15(9):1157. PubMed ID: 19718628
    [No Abstract]   [Full Text] [Related]  

  • 5. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Schmeding M; Kienlein S; Röcken C; Neuhaus R; Neuhaus P; Heidenhain C; Neumann UP
    Transpl Immunol; 2010 Aug; 23(4):156-60. PubMed ID: 20558292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients.
    Tambur AR; Ben-Ari Z; Herrera ND; Klein T; Michowiz R; Mor E
    Hum Immunol; 2005 Jan; 66(1):21-7. PubMed ID: 15620458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
    Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
    Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
    Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
    Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
    Asaoka T; Kato T; Marubashi S; Dono K; Hama N; Takahashi H; Kobayashi S; Takeda Y; Takemasa I; Nagano H; Yoshida H; Ruiz P; Tzakis AG; Matsubara K; Monden M; Doki Y; Mori M
    Liver Transpl; 2009 Dec; 15(12):1738-49. PubMed ID: 19938108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A
    Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C.
    Souza P; Prihoda TJ; Hoyumpa AM; Sharkey FE
    Hum Pathol; 2009 Jan; 40(1):92-7. PubMed ID: 18790517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A; Molina E; Moura R; Bejarano PA; Khaled A; Ruiz P; Arheart K; Berho M; Drachenberg CB; Mendez P; O'Brien C; Jeffers L; Tzakis A; Schiff ER
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.
    Song AT; Mello ES; Alves VA; Cavalheiro Nde P; Melo CE; Bonazzi PR; Tengan FM; Freire MP; Barone AA; D'Albuquerque LA; Abdala E
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):56-64. PubMed ID: 25742264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation.
    Saxena R; Crawford JM; Navarro VJ; Friedman AL; Robert ME
    Mod Pathol; 2002 Sep; 15(9):897-903. PubMed ID: 12218206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
    Molmenti EP; Netto GJ; Murray NG; Smith DM; Molmenti H; Crippin JS; Hoover TC; Jung G; Marubashi S; Sanchez EQ; Gogel B; Levy MF; Goldstein RM; Fasola CG; Gonwa TA; Klintmalm GB
    Liver Transpl; 2002 Jun; 8(6):519-26. PubMed ID: 12037782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients.
    Sundaram SS; Melin-Aldana H; Neighbors K; Alonso EM
    Liver Transpl; 2006 Jan; 12(1):58-64. PubMed ID: 16382471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.